22.07.2013 17:45:02
|
Imris Gets FDA 510K Clearance To Market Visius ICT
(RTTNews) - Imris Inc. (IMRS, IM.TO) has received 510K clearance from FDA to market Visius iCT, a ceiling-mounted intraoperative computed tomography.
VISIUS iCT is a state-of-the-art surgical theater that provides personalized dose management together with diagnostic quality imaging during the surgical procedure to assist surgeons in critical decision making. The 64-slice scanner effortlessly moves into and out of the operating room during surgery using ceiling-mounted rails to ease workflow. This enables multiple room configurations to meet both clinical requirements and increase utilization without compromising image quality or exam speed.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMRIS Incmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu IMRIS Incmehr Analysen
Aktien in diesem Artikel
IMRIS Inc | 0,00 | 0,00% |
|